Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Jan 17;25(6):e14278. doi: 10.1002/acm2.14278

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 The Authors. Journal of Applied Clinical Medical Physics is published by Wiley Periodicals, Inc. on behalf of The American Association of Physicists in Medicine.

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Results of 70−90% prescription IDL optimizations for plans treating 7−10 metastases. (a) Volume of brain tissue receiving specified dose for each IDL optimization for a representative case treating eight metastases. (b) Comparison of V10 for cases treating 7−10 metastases optimized at 70−90% prescription IDLs. (c) Comparison of V12 for cases treating 7−10 metastases optimized at 70−90% prescription IDLs. (d) Comparison of V15 for cases treating 7−10 metastases optimized at 70−90% prescription IDLs (NS: Not statistically significant, *p < 0.05, **p < 0.01, ***p < 0.001).